cancer-related fatigue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Complies with the diagnostic standards for Cancer-Related Fatigue as outlined in the International Classification of Diseases, 10th Edition (ICD-10); (2) Experiences moderate to severe levels of fatigue, quantified as a score of 4 or higher on the Piper Fatigue Scale; (3) Diagnosed with stage I to III breast cancer in female patients; (4) Aged between 18 and 80 years; (5) Achieves a score of 70 or higher on the Karnofsky Performance Status (KPS); (6) Has concluded treatment for breast cancer (including surgery, radiation, chemotherapy, or targeted therapy) at least three months prior, although ongoing hormone therapy for over four weeks is permitted.
Exclusion criteria
Exclusion criteria: (1) Currently pregnant or lactating; (2) Anemic conditions (hemoglobin levels below 110g/L); (3) Demonstrates abnormal thyroid function (free thyroxine levels exceeding 22pmol/L or thyroid-stimulating hormone levels above 5.0uIU/ml); (4) Exhibits liver function abnormalities (levels of aspartate aminotransferase or alanine aminotransferase exceeding twice the normal upper limit); (5) Shows renal function abnormalities (creatinine levels exceeding 1.5 times the upper limit of normal); (6) Suffers from psychiatric disorders or significant cognitive dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Piper Fatigue Scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Interleukin-6 (IL-6) and Interleukin-8 (IL-8);hypothalamic-pituitary-adrenal (HPA) axis-related hormone factors;Karnofsky Performance Scale score; | — |
Countries
China
Contacts
Department of Oncology , Hospital of Chengdu University of Traditional Chinese Medicine